Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents Fulltext Access 4 Pages 2009
Selected Phase III Trials in Multiple Myeloma With Study Start 2008 and 2009 Fulltext Access 4 Pages 2009
Successful Completion of Pregnancy in a Patient With Chronic Myeloid Leukemia Without Active Intervention: A Case Report and Review of the Literature Fulltext Access 4 Pages 2009
Arterial Thrombosis With Immunomodulatory Derivatives in the Treatment of Multiple Myeloma: A Single-Center Case Series and Review of the Literature Fulltext Access 4 Pages 2009
Therapy-Related Acute Myeloid Leukemia Following HIV-Associated Lymphoma Fulltext Access 4 Pages 2009
Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens Fulltext Access 4 Pages 2009
Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience Fulltext Access 4 Pages 2009
Granulomatous Slack Skin: Assessment of Disease Progression and Treatment Response Using Positron Emission Tomography/Computed Tomography Fulltext Access 4 Pages 2009
Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure Fulltext Access 4 Pages 2009
Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease Fulltext Access 4 Pages 2009
Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia Fulltext Access 4 Pages 2009
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells Fulltext Access 4 Pages 2009
Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified Fulltext Access 4 Pages 2009
The first case of de novo B-cell prolymphocytic leukemia with central nervous system involvement: Description of an unreported complication Fulltext Access 4 Pages 2009
Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia Fulltext Access 4 Pages 2009
Systemic mastocytosis in association with plasma cell dyscrasias: Report of a case and review of the literature Fulltext Access 4 Pages 2009
Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations Fulltext Access 4 Pages 2009
Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: A case–control study Fulltext Access 4 Pages 2009
Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia Fulltext Access 4 Pages 2009
Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor Fulltext Access 4 Pages 2009
Peripheral T-cell lymphoma initially suspected with a single lymphoid aggregate and t(4;16)(q26;p13.3) on bone marrow Fulltext Access 4 Pages 2009
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: A report in a case of delayed graft failure Fulltext Access 4 Pages 2009
Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib Fulltext Access 4 Pages 2009
Genetics- and Immune-Related Factors in the Pathogenesis of Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2009
25-hydroxy vitamin D levels in healthy premenopausal women: Association with bone turnover markers and bone mineral density Fulltext Access 4 Pages 2009
Erratum to “Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice” [Bone 43 (2008) 238-248] Fulltext Access 4 Pages 2009
Correlation of quantitative computed tomographic subchondral bone density and ash density in horses Fulltext Access 4 Pages 2009
Hereditary vitamin D resistant rickets: Identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy Fulltext Access 4 Pages 2009
Ophthalmologic Techniques to Assess the Severity of Hyperviscosity Syndrome and the Effect of Plasmapheresis in Patients with Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2009
Novel Antibody-Based Therapeutic Agents Targeting CD70: A Potential Approach for Treating Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2009
AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical Entity Fulltext Access 4 Pages 2009
Fludarabine-Based Combination Therapies for Waldenström's Macroglobulinemia Fulltext Access 4 Pages 2009
High-Resolution Genomic Analysis in Waldenström's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas Fulltext Access 4 Pages 2009
Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response Fulltext Access 4 Pages 2009
Novel Aspects Pertaining to the Relationship of Waldenström's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia Fulltext Access 4 Pages 2009
Durable Long-Term Responses in Patients with Myelodysplastic Syndromes Treated with Lenalidomide Fulltext Access 4 Pages 2009
Multiple Significant Bortezomib-Related Toxicities in One Patient: Case Report and Literature Review Fulltext Access 4 Pages 2009
Multicentric Hyaline-Vascular Type Castleman Disease Presenting as an Epidural Mass Causing Paraplegia: A Case Report Fulltext Access 4 Pages 2009
t(11;14) Plasma Cell Disorder Presents as a True Nonsecretory, Nonproducer Multiple Myeloma Fulltext Access 4 Pages 2009
von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease Fulltext Access 4 Pages 2009
Molecular Monitoring of Patients With Chronic Myeloid Leukemia: Clinical Examples From a Non-Trial Setting Fulltext Access 4 Pages 2009
Successful Use of Full-Dose Dexamethasone, High-Dose Cytarabine, and Cisplatin as Part of Initial Therapy in Non-Hodgkin and Hodgkin Lymphoma with Severe Hepatic Dysfunction Fulltext Access 4 Pages 2009
Low-Dose Gemcitabine Efficacious in Three Patients With Tumor-Stage Mycosis Fungoides Fulltext Access 4 Pages 2009
IGHV Unmutated Status Influences Outcome More Than IGHV1-69 Gene Usage Per Se in Patients With Chronic Lymphocytic Leukemia Fulltext Access 4 Pages 2009
Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis Fulltext Access 4 Pages 2009
Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma Fulltext Access 4 Pages 2009
Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide Fulltext Access 4 Pages 2009
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes Fulltext Access 4 Pages 2009
Acute lymphoblastic leukemia following severe congenital neutropenia or de novo ALL? Fulltext Access 4 Pages 2009
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia Fulltext Access 4 Pages 2009
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer Fulltext Access 4 Pages 2009
SDF1/CXCL12 (−801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia Fulltext Access 4 Pages 2009
Malignant hematopoietic cell lines: In vitro models for the study of plasmacytoid dendritic cell leukemia Fulltext Access 4 Pages 2009
High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma Fulltext Access 4 Pages 2009
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease Fulltext Access 4 Pages 2009
Uncommon lineage switch warrants immunophenotyping even in relapsing leukemia Fulltext Access 4 Pages 2009
Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature Fulltext Access 4 Pages 2009
Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia Fulltext Access 4 Pages 2009
Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia Fulltext Access 4 Pages 2009
Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures Fulltext Access 4 Pages 2009
Thalidomide treatment down-regulates SDF-1α and CXCR4 expression in multiple myeloma patients Fulltext Access 4 Pages 2009
Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia Fulltext Access 4 Pages 2009
Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia Fulltext Access 4 Pages 2009
Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia Fulltext Access 4 Pages 2009
Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses Fulltext Access 4 Pages 2009
Thyroid carcinoma in Pakistan: A retrospective review of 998 cases from an academic referral center Fulltext Access 4 Pages 2009
Conjunctival malt lymphoma successfully treated with single agent rituximab therapy Fulltext Access 4 Pages 2009
Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells Fulltext Access 4 Pages 2009
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia Fulltext Access 4 Pages 2009
der(1)t(1;19)(p13;p13.1) in two elderly patients with myeloid neoplasms: New case reports and review of the literature Fulltext Access 4 Pages 2009
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome? Fulltext Access 4 Pages 2009
Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin Fulltext Access 4 Pages 2009
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes Fulltext Access 4 Pages 2009
Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH) Fulltext Access 4 Pages 2009
p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma Fulltext Access 4 Pages 2009
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal Fulltext Access 4 Pages 2009
JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN) Fulltext Access 4 Pages 2009
Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3 Fulltext Access 4 Pages 2009
Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia Fulltext Access 4 Pages 2009
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics Fulltext Access 4 Pages 2009
Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFκB activity in Follicular Lymphoma Fulltext Access 4 Pages 2009
Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia Fulltext Access 4 Pages 2009
Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis Fulltext Access 4 Pages 2009
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience Fulltext Access 4 Pages 2009